{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:12:09Z","timestamp":1774307529909,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M730676"],"award-info":[{"award-number":["2023M730676"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271499"],"award-info":[{"award-number":["82271499"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fragile X-associated tremor\/ataxia syndrome (FXTAS) is a neurodegenerative disorder caused by CGG repeat expansion of <jats:italic>FMR1<\/jats:italic> gene. Both FXTAS and neuronal intranuclear inclusion disease (NIID) belong to polyglycine diseases and present similar clinical, radiological, and pathological features, making it difficult to distinguish these diseases. Reversible encephalitis-like attacks are often observed in NIID. It is unclear whether they are presented in FXTAS and can be used for differential diagnosis of NIID and FXTAS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 63-year-old Chinese male with late-onset gait disturbance, cognitive decline, and reversible attacks of fever, consciousness impairment, dizziness, vomiting, and urinary incontinence underwent neurological assessment and examinations, including laboratory tests, electroencephalogram test, imaging, skin biopsy, and genetic test. Brain MRI showed T2 hyperintensities in middle cerebellar peduncle and cerebrum, in addition to cerebellar atrophy and DWI hyperintensities along the corticomedullary junction. Lesions in the brainstem were observed. Skin biopsy showed p62-positive intranuclear inclusions. The possibilities of hypoglycemia, lactic acidosis, epileptic seizures, and cerebrovascular attacks were excluded. Genetic analysis revealed CGG repeat expansion in <jats:italic>FMR1<\/jats:italic> gene, and the number of repeats was 111. The patient was finally diagnosed as FXTAS. He received supportive treatment as well as symptomatic treatment during hospitalization. His encephalitic symptoms were completely relieved within one week.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is a detailed report of a case of FXTAS with reversible encephalitis-like episodes. This report provides new information for the possible and rare features of FXTAS, highlighting that encephalitis-like episodes are common in polyglycine diseases and unable to be used for differential diagnosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-024-03641-z","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T06:01:50Z","timestamp":1715061710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Reversible encephalitis-like episodes in fragile X-associated tremor\/ataxia syndrome: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Shaoping","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangye","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"3641_CR1","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1212\/WNL.0b013e318271f7ff","volume":"79 18","author":"E Apartis","year":"2012","unstructured":"Apartis E, Blancher A, Meissner WG, Guyant-Mar\u00e9chal L, Malt\u00eate D, De Broucker T, et al. FXTAS: new insights and the need for revised diagnostic criteria. Neurology. 2012;79 18:1898\u2013907. https:\/\/doi.org\/10.1212\/WNL.0b013e318271f7ff.","journal-title":"Neurology"},{"key":"3641_CR2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/wco.0000000000000954","volume":"34 4","author":"R Hagerman","year":"2021","unstructured":"Hagerman R, Hagerman P. Fragile X-associated tremor\/ataxia syndrome: pathophysiology and management. Curr Opin Neurol. 2021;34 4:541\u20136. https:\/\/doi.org\/10.1097\/wco.0000000000000954.","journal-title":"Curr Opin Neurol"},{"key":"3641_CR3","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1002\/mds.21493","volume":"22 14","author":"E Berry-Kravis","year":"2007","unstructured":"Berry-Kravis E, Abrams L, Coffey SM, Hall DA, Greco C, Gane LW, et al. Fragile X-associated tremor\/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disorders: Official J Mov Disorder Soc. 2007;22 14:2018\u201330. https:\/\/doi.org\/10.1002\/mds.21493.","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"key":"3641_CR4","doi-asserted-by":"publisher","unstructured":"Toko M, Ohshita T, Kurashige T, Morino H, Kume K, Yamashita H, et al. FXTAS is difficult to differentiate from neuronal intranuclear inclusion disease through skin biopsy: a case report. BMC Neurol. 2021;21(1:396). https:\/\/doi.org\/10.1186\/s12883-021-02425-z.","DOI":"10.1186\/s12883-021-02425-z"},{"issue":"3","key":"3641_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00702-021-02313-3","volume":"128","author":"X Lu","year":"2021","unstructured":"Lu X, Hong D. Neuronal intranuclear inclusion disease: recognition and update. J Neural Transmission (Vienna Austria: 1996). 2021;128(3):295\u2013303. https:\/\/doi.org\/10.1007\/s00702-021-02313-3.","journal-title":"J Neural Transmission (Vienna Austria: 1996)"},{"key":"3641_CR6","doi-asserted-by":"publisher","first-page":"843014","DOI":"10.3389\/fgene.2022.843014","volume":"13","author":"M Boivin","year":"2022","unstructured":"Boivin M, Charlet-Berguerand N. Trinucleotide CGG repeat diseases: an Expanding Field of Polyglycine Proteins? Front Genet. 2022;13:843014. https:\/\/doi.org\/10.3389\/fgene.2022.843014.","journal-title":"Front Genet"},{"key":"3641_CR7","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00401-021-02375-3","volume":"142 6","author":"S Zhong","year":"2021","unstructured":"Zhong S, Lian Y, Luo W, Luo R, Wu X, Ji J, et al. Upstream open reading frame with NOTCH2NLC GGC expansion generates polyglycine aggregates and disrupts nucleocytoplasmic transport: implications for polyglycine diseases. Acta Neuropathol. 2021;142 6:1003\u201323. https:\/\/doi.org\/10.1007\/s00401-021-02375-3.","journal-title":"Acta Neuropathol"},{"key":"3641_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-329772","author":"Y Tian","year":"2022","unstructured":"Tian Y, Zhou L, Gao J, Jiao B, Zhang S, Xiao Q, et al. Clinical features of NOTCH2NLC-related neuronal intranuclear inclusion disease. J Neurol Neurosurg Psychiatry. 2022. https:\/\/doi.org\/10.1136\/jnnp-2022-329772.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3641_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0140-6736(74)91639-0","volume":"2 7872","author":"G Teasdale","year":"1974","unstructured":"Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet (London England). 1974;2 7872:81\u20134. https:\/\/doi.org\/10.1016\/s0140-6736(74)91639-0.","journal-title":"Lancet (London England)"},{"key":"3641_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53 4","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53 4:695\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"3641_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/mdc3.12944","volume":"7","author":"F Islam","year":"2020","unstructured":"Islam F, Lee W. A case of generalized Chorea presenting as an early feature of Fragile-X Associated Tremor\/Ataxia Syndrome. Mov Disorders Clin Pract. 2020;7(4):464\u20136. https:\/\/doi.org\/10.1002\/mdc3.12944.","journal-title":"Mov Disorders Clin Pract"},{"key":"3641_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3325\/cmj.2017.58.310","volume":"58 4","author":"M Lechpammer","year":"2017","unstructured":"Lechpammer M, Mart\u00ednez Cerde\u0144o V, Hunsaker MR, Hah M, Gonzales H, Tisch S, et al. Concomitant occurrence of FXTAS and clinically defined sporadic inclusion body myositis: report of two cases. Croatian Med J. 2017;58 4:310\u20135. https:\/\/doi.org\/10.3325\/cmj.2017.58.310.","journal-title":"Croatian Med J"},{"key":"3641_CR13","doi-asserted-by":"publisher","unstructured":"Li M, Li K, Li X, Tian Y, Shen L, Wu G, et al. Multiple reversible encephalitic attacks: a rare manifestation of neuronal intranuclear inclusion disease. BMC Neurol. 2020;20(1:125). https:\/\/doi.org\/10.1186\/s12883-020-01712-5.","DOI":"10.1186\/s12883-020-01712-5"},{"key":"3641_CR14","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1001\/jamaneurol.2018.2333","volume":"75 12","author":"F Xiao","year":"2018","unstructured":"Xiao F, Tian X, Wang XF. Cerebral atrophy and Leukoencephalopathy in a Young Man presenting with encephalitic episodes. JAMA Neurol. 2018;75 12:1563\u20134. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2333.","journal-title":"JAMA Neurol"},{"key":"3641_CR15","doi-asserted-by":"publisher","unstructured":"Huang Y, Jin G, Zhan QL, Tian Y, Shen L. Adult-onset neuronal intranuclear inclusion disease, with both stroke-like onset and encephalitic attacks: a case report. BMC Neurol. 2021;21(1:142). https:\/\/doi.org\/10.1186\/s12883-021-02164-1.","DOI":"10.1186\/s12883-021-02164-1"},{"key":"3641_CR16","doi-asserted-by":"publisher","first-page":"837844","DOI":"10.3389\/fneur.2022.837844","volume":"13","author":"F Xie","year":"2022","unstructured":"Xie F, Hu X, Liu P, Zhang D. A case report of neuronal intranuclear inclusion Disease presenting with recurrent migraine-like attacks and cerebral edema: a mimicker of MELAS. Front Neurol. 2022;13:837844. https:\/\/doi.org\/10.3389\/fneur.2022.837844.","journal-title":"Front Neurol"},{"key":"3641_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ebcr.2019.01.007","volume":"11","author":"K Shindo","year":"2019","unstructured":"Shindo K, Tsuchiya M, Hata T, Ichinose Y, Koh K, Sone J, et al. Non-convulsive status epilepticus associated with neuronal intranuclear inclusion disease: a case report and literature review. Epilepsy Behav case Rep. 2019;11:103\u20136. https:\/\/doi.org\/10.1016\/j.ebcr.2019.01.007.","journal-title":"Epilepsy Behav case Rep"},{"key":"3641_CR18","doi-asserted-by":"publisher","unstructured":"Orsucci D, Lorenzetti L, Baldinotti F, Rossi A, Vitolo E, Gheri FL, et al. Fragile X-Associated Tremor\/Ataxia syndrome (FXTAS): a gender perspective. J Clin Med. 2022;11(4). https:\/\/doi.org\/10.3390\/jcm11041002.","DOI":"10.3390\/jcm11041002"},{"issue":"Pt 12","key":"3641_CR19","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1093\/brain\/aww249","volume":"139","author":"J Sone","year":"2016","unstructured":"Sone J, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S, et al. Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain. 2016;139(Pt 12):3170\u201386. https:\/\/doi.org\/10.1093\/brain\/aww249.","journal-title":"Brain"},{"key":"3641_CR20","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1212\/cpj.0000000000000389","volume":"7 6","author":"K Fujita","year":"2017","unstructured":"Fujita K, Osaki Y, Miyamoto R, Shimatani Y, Abe T, Sumikura H, et al. Neurologic attack and dynamic perfusion abnormality in neuronal intranuclear inclusion disease. Neurol Clin Pract. 2017;7 6:e39\u201342. https:\/\/doi.org\/10.1212\/cpj.0000000000000389.","journal-title":"Neurol Clin Pract"},{"issue":"4","key":"3641_CR21","doi-asserted-by":"publisher","first-page":"e601","DOI":"10.1212\/nxg.0000000000000601","volume":"7","author":"M Kikumoto","year":"2021","unstructured":"Kikumoto M, Nezu T, Shiga Y, Motoda A, Toko M, Kurashige T, et al. Case of neuronal intranuclear inclusion Disease with dynamic perfusion changes lacking typical signs on diffusion-weighted imaging. Neurol Genet. 2021;7(4):e601. https:\/\/doi.org\/10.1212\/nxg.0000000000000601.","journal-title":"Neurol Genet"},{"key":"3641_CR22","doi-asserted-by":"publisher","unstructured":"Hall DA, Hermanson M, Dunn E, Stebbins G, Merkitch D, Ouyang B et al. The Corpus Callosum Splenium sign in Fragile X-Associated Tremor Ataxia Syndrome. Movement disorders clinical practice. 2017;4 3:383\u20138; https:\/\/doi.org\/10.1002\/mdc3.12449.","DOI":"10.1002\/mdc3.12449"},{"key":"3641_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fped.2020.00266","volume":"8","author":"K Johnson","year":"2020","unstructured":"Johnson K, Herring J, Richstein J, Fragile X. Premutation Associated conditions (FXPAC). Front Pead. 2020;8:266. https:\/\/doi.org\/10.3389\/fped.2020.00266.","journal-title":"Front Pead"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-03641-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T06:02:55Z","timestamp":1715061775000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03641-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3641"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-03641-z","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"assertion":[{"value":"23 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As the patient has cognitive decline, the legal guardian has provided informed consent to participate on their behalf.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s guardian for publication of this case report. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}